Immunic Showcases Promising Vidofludimus Calcium Data at ECTRIMS 2025 At ECTRIMS 2025, Immunic presented significant findings on Vidofludimus Calcium, showing its potential to improve disability in multiple sclerosis patients.

Immunic Showcases Promising Vidofludimus Calcium Data at ECTRIMS 2025 #USA #New_York #Immunic #Vidofludimus #ECTRIMS_2025